Applied Therapeutics, Inc.
ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF PHOSPHOMANNOMUTASE 2 DEFICIENCY
Last updated:
Abstract:
The disclosure relates to methods for treating PMM2-CDG using aldose reductase inhibitors.
Status:
Application
Type:
Utility
Filling date:
7 Apr 2022
Issue date:
21 Jul 2022